CIN (also called contrast-induced acute kidney injury, CI-AKI) is defined as a rise in serum creatinine of ≥25% OR ≥44 μmol/L (0.5 mg/dL) above baseline within 48–72 hours of intravascular iodinated contrast administration, in the absence of another cause.
Critical Definition: CIN = creatinine rise ≥25% OR ≥44 μmol/L within 48–72 hrs after contrast. Peak creatinine usually occurs at 3–5 days. Most cases resolve by 7–10 days.
Pathophysiology
Renal vasoconstriction: Contrast causes direct vasoconstriction of afferent arterioles, reducing medullary blood flow
Direct tubular toxicity: Iodinated contrast is directly toxic to tubular epithelial cells — causes apoptosis and necrosis
Free radical generation: Reactive oxygen species damage tubular cells, amplified by pre-existing renal compromise
Nursing note: Iso-osmolar contrast (iodixanol) preferred in high-risk patients per most GCC centre protocols.
CIN is often clinically silent — creatinine rise is detected on post-procedure blood tests. Monitor for:
Oliguria (<0.5 mL/kg/hr for >6 hrs) — early warning sign
Rising urea and creatinine on day 1–3 post-procedure
Peripheral oedema if fluid balance becomes positive
In severe cases: nausea, fatigue, confusion (uraemia)
Occasionally non-oliguric CIN — creatinine rises but urine output preserved
Peak creatinine: Days 3–5. Most return to baseline by 7–10 days. Persistent renal failure (>30 days) occurs in ~1% — higher in haemodynamically compromised patients.
Mehran Risk Score
The Mehran score is the most widely used CIN risk stratification tool in GCC cardiac catheterisation labs and radiology departments.
Risk Factor
Points
Hypotension (SBP <80 mmHg for ≥1 hr requiring support)
5
Intra-aortic balloon pump
5
Congestive heart failure (NYHA III–IV or acute pulmonary oedema)
5
Age >75 years
4
Anaemia (Hct <39% males, <36% females)
3
Diabetes mellitus
3
Contrast volume (per 100 mL above baseline)
1 per 100mL
Serum creatinine >133 μmol/L (1.5 mg/dL)
4
eGFR 40–60 mL/min/1.73m²
2
eGFR 20–40 mL/min/1.73m²
4
eGFR <20 mL/min/1.73m²
6
Score Interpretation
Score
Risk Category
CIN Risk
Dialysis Risk
≤5
Low
7.5%
0.04%
6–10
Moderate
14%
0.12%
11–16
High
26%
1.1%
≥16
Very High
57%
12.6%
🧮 CIN Risk Calculator (Mehran Score)
Additional high-risk indicators: Nephrotoxic drugs (NSAIDs, aminoglycosides, vancomycin), dehydration, multiple myeloma, single functioning kidney, emergency procedures (less time for pre-hydration).
Prevention Bundle
Gold Standard Prevention: IV 0.9% NaCl 1 mL/kg/hr for 3–12 hrs pre + 6–12 hrs post procedure. Iso-osmolar contrast agent. Minimum contrast volume. Discontinue nephrotoxins.
IV Hydration Protocol
Setting
Regimen
Elective procedure (low–moderate risk)
0.9% NaCl 1 mL/kg/hr 3–12 hrs before + 6 hrs after
High-risk patient
0.9% NaCl 1 mL/kg/hr 12 hrs before + 12 hrs after
Obese patient
0.9% NaCl 1 mL/kg/hr (ideal body weight), max 100 mL/hr
CHF/reduced EF patient
0.5 mL/kg/hr with close monitoring; consider isotonic bicarbonate
Emergency procedure
Bolus 300 mL NaCl over 1 hr pre + 1 mL/kg/hr post
Metformin Management — CRITICAL Nursing Knowledge
Rule: Withhold metformin from time of contrast exposure if eGFR <60 OR IV contrast used. Restart only 48 hours after procedure once serum creatinine confirmed stable.
eGFR ≥60, no CIN risk: Can continue metformin; monitor creatinine
eGFR 45–60: Withhold at time of contrast; restart 48 hrs later if creatinine stable
eGFR <45: Withhold metformin; restart only after nephrology review
Nursing role: Check metformin on medication reconciliation; document hold and restart date; educate patient
Medications to Withhold Pre-Procedure
Drug Class
Action
Rationale
NSAIDs
Stop 24–48 hrs before
Reduce renal prostaglandins → worsen ischaemia
ACE inhibitors
Withhold 24 hrs before (high-risk)
Reduce GFR, worsen contrast effect
ARBs
Withhold 24 hrs before (high-risk)
Same as ACEi
Metformin
Withhold if eGFR <60
Lactic acidosis risk
Aminoglycosides
Delay contrast if possible
Additive tubular toxicity
NAC (Mucomyst) was historically used for CIN prevention (600–1200 mg PO/BD day before + day of procedure). Current evidence (PRESERVE trial 2018) shows NO benefit over IV saline alone. Most GCC guidelines no longer recommend routine NAC. However, some centres continue use due to safety profile and low cost.
Sodium bicarbonate: Isotonic sodium bicarbonate (1.26%) vs NaCl — PRESERVE trial showed equivalent outcomes. Some high-risk centres still prefer bicarbonate in patients with metabolic acidosis.
Maximum safe contrast volume = 3–5 × eGFR (e.g., eGFR 30 → maximum 90–150 mL)
Use iso-osmolar contrast (iodixanol) preferentially in eGFR <60
Dilute contrast where imaging quality permits
Consider staging procedures (split contrast load over 48–72 hrs)
CO₂ angiography as contrast alternative for peripheral studies in severe CKD
Nursing documentation: Record baseline creatinine, contrast type and volume given, pre/post hydration volumes, metformin hold date, creatinine trend, and any escalation actions in the procedure notes.
GCC-Specific Context
High-Risk Patient Populations in GCC
Type 2 diabetes prevalence: 15–25% across GCC — highest global rates. Diabetic nephropathy is leading cause of CKD in the region
Consanguinity: Higher rates of hereditary renal disease (e.g., ADPKD, Alport syndrome) → baseline CKD even in young patients
Contrast volume in cardiac cath labs: High-volume cardiac catheterisation across Saudi Arabia, UAE, Qatar — radial access approach reduces contrast volume vs femoral
Heat exposure and dehydration: Patients presenting in summer months may be dehydrated before contrast procedures — baseline assessment essential
GCC Centre Protocols
Centre/Country
Standard Pre-Hydration
Preferred Contrast
KFSH&RC Saudi Arabia
NaCl 1 mL/kg/hr 3–12 hrs
Iodixanol (iso-osmolar)
Cleveland Clinic Abu Dhabi
NaCl or NaHCO₃ 1 mL/kg/hr
Iodixanol or low-osmolar
HMC Qatar
NaCl 1 mL/kg/hr per KDIGO
Iodixanol for CKD≥3b
Al-Sabah Hospital Kuwait
NaCl 1 mL/kg/hr + NAC
Low-osmolar standard
DHA/SCFHS/QCHP Exam Relevance
CIN definition (25% or 44 μmol/L rise) frequently tested
Metformin withholding rules — common MCQ topic
Mehran score components tested in nephrology/radiology nursing modules
Hydration protocol (1 mL/kg/hr NaCl) is exam standard answer
Iso-osmolar vs high-osmolar contrast agent preference tested
Exam MCQs — DHA / SCFHS / QCHP
Q1. A patient with eGFR 35 mL/min/1.73m² and type 2 diabetes is scheduled for coronary angiography. Which contrast agent should the nurse advocate for?
✅ B — Iso-osmolar (iodixanol) is the preferred agent in high-risk patients (CKD + diabetes). It has the lowest osmolality (~290 mOsm/kg) and is associated with the least tubular toxicity in this population.
Q2. A patient taking metformin 1000 mg BD has an eGFR of 52 mL/min/1.73m². They are scheduled for a CT pulmonary angiogram with IV contrast. What should the nurse do regarding metformin?
✅ C — Withhold metformin when eGFR <60 AND IV contrast is used. Restart only after 48 hours once creatinine is confirmed stable to prevent metformin accumulation and lactic acidosis risk.
Q3. According to the Mehran Risk Score, which of the following carries the HIGHEST point value?
✅ D — eGFR <20 mL/min/1.73m² carries 6 points — the highest single factor on the Mehran score. Severely reduced GFR indicates minimal renal reserve and very high susceptibility to contrast nephrotoxicity.
Q4. A patient has undergone coronary angiography. Post-procedure, their urine output is 0.3 mL/kg/hr at 4 hours. Serum creatinine was 88 μmol/L pre-procedure. What is the PRIORITY nursing action?
✅ C — Oliguria (<0.5 mL/kg/hr) post-contrast requires prompt assessment of fluid status and escalation. Furosemide is NOT recommended in CIN prevention or treatment. A large unguided fluid bolus may worsen fluid overload in cardiac patients.